![CME Programme CSHK mw_menu_data_5564_56eb2b174e5e3.jpg](https://cshk.org/site/CSHK/upload/mw_menu_data/file/mw_menu_data_5564_56eb2b174e5e3.jpg)
CME Programme
-
Non-Regular Activities
Legacy of TAGRISSO: Hope for EGFR-mutated NSCLC PatientsDate: 18/07/2022 Enquiries: AstraZeneca (Hong Kong) CME Points Awarded: 2 points
CME Programme
Date: | 18/07/2022 |
Enquiries: | AstraZeneca (Hong Kong) |
CME Points Awarded: | 2 points |